Ongoing clinical trials evaluating PARP inhibitors in prostate cancer. | Download Scientific Diagram
Dual mechanism of action of PARPi. Notes: Olaparib inhibits parylation... | Download Scientific Diagram
IJMS | Free Full-Text | Sesquiterpene Lactones Potentiate Olaparib-Induced DNA Damage in p53 Wildtype Cancer Cells | HTML
A decade of clinical development of PARP inhibitors in perspective - Annals of Oncology
Role of PARP Inhibitors in BRCA-Related Malignancies
![PDF] Role of Olaparib as Maintenance Treatment for Ovarian Cancer: The Evidence to Date | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/13ae57a8a88e3b3bdf417f3001cda897570dbaf3/7-Table4-1.png "PDF] Role of Olaparib as Maintenance Treatment for Ovarian Cancer: The Evidence to Date | Semantic Scholar")
PDF] Role of Olaparib as Maintenance Treatment for Ovarian Cancer: The Evidence to Date | Semantic Scholar
LYNPARZA® (olaparib) reduced risk of death by 32% in the adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer | Business Wire
Role of PARP Inhibitors in BRCA-Related Malignancies
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial - The Lancet Oncology
BRCA, HRR Deficiency, and PARP Inhibitors - ppt download
Mechanism of Action of PARP Inhibitors. Note: in the presence of a PARP... | Download Scientific Diagram
References in PARP Inhibitors as P-glyoprotein Substrates - Journal of Pharmaceutical Sciences
BRCA-mutant pancreatic ductal adenocarcinoma | British Journal of Cancer
Nausea and Vomiting: Managing Side Effects From PARP Inhibitors
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
Mechanism of Action of PARP Inhibitors. Note: in the presence of a PARP... | Download Scientific Diagram
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
PARP inhibitors: Clinical utility and possibilities of overcoming resistance - Gynecologic Oncology
PARP inhibitor - Wikipedia
PARP Inhibition | PARP Inhibitor Review
Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells
LYNPARZA™ (olaparib) for Advanced Ovarian Cancer - Cancer Therapy Advisor
Nausea and Vomiting: Managing Side Effects From PARP Inhibitors
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
